PURPOSE: Recent research, although inconsistent, indicates that socioeconomic status (SES) may be associated with hormone receptor (HR) status. This study aims to examine the association between SES and breast cancer HR status within and across racial/ethnic groups stratified by age at diagnosis and tumor stage. METHODS: The study subjects were 184,602 women with incident breast cancer diagnosed during 2004-2007 and identified from the National Cancer Institute's Surveillance, Epidemiology and End Results program. Log-binomial regression assessed the risk of having breast tumors that were (1) HR-negative versus HR-positive and (2) HR-unknown versus HR-known between women who, at the time of diagnosis, were residing in high or medium poverty areas compared to low poverty areas. RESULTS: High poverty areas tended to have a greater prevalence of HR-negative tumors compared to more affluent areas. Although not always significant, this was observed among non-Hispanic white and Hispanic women regardless of age-tumor stage category, and only among young, non-Hispanic black women and non-Hispanic Asian/Pacific Islander women with regional and distant stage. High poverty areas also tended to have a greater prevalence of HR-unknown tumors compared to more affluent areas. Furthermore, significant trends between HR status and poverty level varied by race/ethnicity, age, and tumor stage. CONCLUSIONS: Poverty may be related to breast cancer negative and unknown HR status. These findings suggest the effects of non-genetic factors on biochemical features of breast cancer, as well as imply a clinical importance to improve HR measurement or recording for low socioeconomic breast cancer patients.
PURPOSE: Recent research, although inconsistent, indicates that socioeconomic status (SES) may be associated with hormone receptor (HR) status. This study aims to examine the association between SES and breast cancer HR status within and across racial/ethnic groups stratified by age at diagnosis and tumor stage. METHODS: The study subjects were 184,602 women with incident breast cancer diagnosed during 2004-2007 and identified from the National Cancer Institute's Surveillance, Epidemiology and End Results program. Log-binomial regression assessed the risk of having breast tumors that were (1) HR-negative versus HR-positive and (2) HR-unknown versus HR-known between women who, at the time of diagnosis, were residing in high or medium poverty areas compared to low poverty areas. RESULTS: High poverty areas tended to have a greater prevalence of HR-negative tumors compared to more affluent areas. Although not always significant, this was observed among non-Hispanic white and Hispanic women regardless of age-tumor stage category, and only among young, non-Hispanic black women and non-Hispanic Asian/Pacific Islander women with regional and distant stage. High poverty areas also tended to have a greater prevalence of HR-unknown tumors compared to more affluent areas. Furthermore, significant trends between HR status and poverty level varied by race/ethnicity, age, and tumor stage. CONCLUSIONS: Poverty may be related to breast cancer negative and unknown HR status. These findings suggest the effects of non-genetic factors on biochemical features of breast cancer, as well as imply a clinical importance to improve HR measurement or recording for low socioeconomic breast cancerpatients.
Authors: Juhua Luo; Candyce H Kroenke; Michael Hendryx; Aladdin H Shadyab; Nianjun Liu; Xiwei Chen; Fengge Wang; Fridtjof Thomas; Nazmus Saquib; Lihong Qi; Ting-Yuan David Cheng; Rhonda Arthur; Jean Wactawski-Wende Journal: Breast Cancer Res Treat Date: 2021-03-07 Impact factor: 4.872
Authors: Rhonda-Lee F Aoki; Stephen P Uong; Scarlett Lin Gomez; Stacey E Alexeeff; Bette J Caan; Lawrence H Kushi; Jacqueline M Torres; Alice Guan; Alison J Canchola; Brittany N Morey; Katherine Lin; Candyce H Kroenke Journal: Cancer Date: 2021-08-20 Impact factor: 6.860
Authors: Ugonna Ihenacho; Ann S Hamilton; Wendy J Mack; Anna H Wu; Jennifer B Unger; Dorothy R Pathak; Kelly A Hirko; Richard T Houang; Michael F Press; Kendra L Schwartz; Lydia R Marcus; Ellen M Velie Journal: Breast Cancer Res Treat Date: 2022-08-04 Impact factor: 4.624
Authors: Marc A Emerson; Yvonne M Golightly; Xianming Tan; Allison E Aiello; Katherine E Reeder-Hayes; Andrew F Olshan; H Shelton Earp; Melissa A Troester Journal: Cancer Causes Control Date: 2020-01-16 Impact factor: 2.506
Authors: Marc A Emerson; Katherine E Reeder-Hayes; Heather J Tipaldos; Mary E Bell; Marina R Sweeney; Lisa A Carey; H Shelton Earp; Andrew F Olshan; Melissa A Troester Journal: Curr Breast Cancer Rep Date: 2020-05-14
Authors: Bo Qin; Riddhi A Babel; Jesse J Plascak; Yong Lin; Antoinette M Stroup; Noreen Goldman; Christine B Ambrosone; Kitaw Demissie; Chi-Chen Hong; Elisa V Bandera; Adana A M Llanos Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-11-24 Impact factor: 4.090
Authors: Matthew P Banegas; Li Tao; Sean Altekruse; William F Anderson; Esther M John; Christina A Clarke; Scarlett L Gomez Journal: Breast Cancer Res Treat Date: 2014-02-28 Impact factor: 4.624